Not Available
Copyright 2000 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
We read with interest the article by Mehta and Martin1 titled "A Case of Pemphigus Vulgaris Improved by Cigarette Smoking." We have a better explanation why cigarette smoking might be expected to improve skin lesions of patients with pemphigus vulgaris, particularly when nicotine in cigarette smoke contacts mucous membranes.
Human keratinocytes contain an elaborate acetylcholine network. Specifically, human keratinocytes synthesize, store, release, and degrade acetylcholine.2 Keratinocytes contain choline acetyltransferase and acetylcholinesterase,2 and have on their cell membranes both muscarinic and nicotinic receptors for acetylcholine.3 - 4 Both nicotinic and muscarinic acetylcholine receptors regulate cell-to-cell adhesion of human keratinocytes (reviewed in Grando5 ). Interaction of nicotine (and other nicotinic agonists) with nicotinic acetylcholine receptors on keratinocytes opens ion gates in the cell membrane to help increase cell-to-cell adherence, stop acantholysis, and stimulate keratinocytes to move laterally to heal erosions.6
We believe the keratinocyte cholinergic system is altered in pemphigus.7 Keratinocytes undergoing acantholysis in a tissue culture plate can be quickly restored to confluence by adding acetylcholine.8 Therefore, in a patient such as the one described by Mehta and Martin,1 nicotine might (1) compete with the disease-causing pemphigus antibodies preventing them from attaching to keratinocytes or (2) block the intracellular signaling pathways that mediate the acantholytic effects of pemphigus antibodies. Approximately 85% of patients with pemphigus develop antibodies in their serum to one or more types of keratinocyte acetylcholine receptors.9
Since human keratinocytes have nicotinic acetylcholine receptors, and since nicotine can bind to them, and since activation of nicotinic cholinergic receptors increases cell-to-cell adhesion and promotes lateral migration of keratinocytes, one might predict that smoking would, indeed, improve pemphigus. Nicotine could be delivered to keratinocytes of mucous membranes either topically through the smoke or systemically via absorbed nicotine.
One might also predict that nicotinamide, like nicotine, might improve pemphigus, since it too is a nicotinic agonist.10 Additionally, nicotinamide inhibits the enzyme acetylcholinesterase that degrades acetylcholine.11 Indeed, nicotinamide has helped patients with pemphigus too (reviewed in Chaffins et al12 ).
Thus, the observation that a patient's erosions of the buccal mucosa and blisters on his face and body improved after cigarette smoking suggests that nicotine and other cholinergic agents might help certain patients with pemphigus. The results of our studies defining the keratinocyte cholinergic network provide a rationale for their use.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.